PT3010535T - Péptidos de toxoide derivados de modulina solúvel em fenol, delta toxina, superantigénios e suas fusões - Google Patents

Péptidos de toxoide derivados de modulina solúvel em fenol, delta toxina, superantigénios e suas fusões

Info

Publication number
PT3010535T
PT3010535T PT148135122T PT14813512T PT3010535T PT 3010535 T PT3010535 T PT 3010535T PT 148135122 T PT148135122 T PT 148135122T PT 14813512 T PT14813512 T PT 14813512T PT 3010535 T PT3010535 T PT 3010535T
Authority
PT
Portugal
Prior art keywords
superantigens
fusions
peptides derived
soluble modulin
delta toxin
Prior art date
Application number
PT148135122T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Integrated Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52105236&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3010535(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Integrated Biotherapeutics Inc filed Critical Integrated Biotherapeutics Inc
Publication of PT3010535T publication Critical patent/PT3010535T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT148135122T 2013-06-19 2014-06-18 Péptidos de toxoide derivados de modulina solúvel em fenol, delta toxina, superantigénios e suas fusões PT3010535T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361836959P 2013-06-19 2013-06-19

Publications (1)

Publication Number Publication Date
PT3010535T true PT3010535T (pt) 2020-07-03

Family

ID=52105236

Family Applications (1)

Application Number Title Priority Date Filing Date
PT148135122T PT3010535T (pt) 2013-06-19 2014-06-18 Péptidos de toxoide derivados de modulina solúvel em fenol, delta toxina, superantigénios e suas fusões

Country Status (7)

Country Link
US (2) US9815872B2 (cg-RX-API-DMAC7.html)
EP (1) EP3010535B1 (cg-RX-API-DMAC7.html)
JP (1) JP6632974B2 (cg-RX-API-DMAC7.html)
CA (1) CA2916231C (cg-RX-API-DMAC7.html)
DK (1) DK3010535T3 (cg-RX-API-DMAC7.html)
PT (1) PT3010535T (cg-RX-API-DMAC7.html)
WO (1) WO2014205111A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014205111A1 (en) 2013-06-19 2014-12-24 Integrated Biotherapeutics, Inc. Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof
WO2018037408A1 (en) * 2016-08-22 2018-03-01 Technion Research & Development Foundation Limited Antimicrobial peptides and uses thereof
EP3532618A4 (en) * 2016-10-27 2020-05-20 MedImmune, LLC SIGNAL POLYPEPTIDES FOR IMPROVED PROTEIN SECRETION
CN107224575B (zh) * 2017-03-06 2018-11-09 浙江海隆生物科技有限公司 奶牛金黄色葡萄球菌乳房炎亚单位疫苗的组合物及其制备方法和应用
US11260120B2 (en) 2017-07-27 2022-03-01 Integrated Biotherapeutic Vaccines, Inc. Immunogenic composition comprising a fusion peptide derived from superantigen toxoids
BR112023003815A2 (pt) 2020-12-18 2023-10-24 Biomedizinische Forschung & Bio Produkte Ag Uma toxina da exotoxina estafilocócica b (seb) desintoxicada, antígeno de vacina protetora e preparação de vacina, é utilizada na prevenção ou tratamento de uma infecção bacteriana expressando superantígeno estafilocócico, método de produção da toxina seb desintoxicada, molécula de ácido nucleico que codifica a toxina seb desintoxicada, célula hospedeira recombinante compreendendo a molécula de ácido nucleico
US12370235B2 (en) 2021-03-04 2025-07-29 University Of Saskatchewan Synthetic, non-natural antimicrobial peptides inspired by Staphylococcus auricularis delta toxin
GR1010289B (el) * 2021-04-27 2022-08-29 Integrated Biotherapeutic Vaccines, Inc., Τοξοειδη πεπτιδια που προερχονται απο διαλυτη σε φαινολη μοδουλινη, τοξινη δελτα, υπεραντιγονα και συντηξεις αυτων
CN113234125B (zh) * 2021-05-10 2022-12-06 华东理工大学 自组装多肽、多肽水凝胶及其制备方法和用途
WO2023227563A1 (en) 2022-05-23 2023-11-30 Biomedizinische Forschung & Bio-Produkte AG Protective staphylococcal exotoxin vaccine
WO2023247747A1 (en) 2022-06-23 2023-12-28 Biomedizinische Forschung & Bio-Produkte AG Protective staphylococcal exotoxin vaccine

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US6593114B1 (en) * 1996-01-05 2003-07-15 Human Genome Sciences, Inc. Staphylococcus aureus polynucleotides and sequences
TW517061B (en) * 1996-03-29 2003-01-11 Pharmacia & Amp Upjohn Ab Modified/chimeric superantigens and their use
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6713284B2 (en) 1997-06-25 2004-03-30 The United States Of America As Represented By The Secretary Of The Army Bacterial superantigen vaccines
US7087235B2 (en) 1997-06-25 2006-08-08 The United States Of America As Represented By The Secretary Of The Army Fusion protein of streptococcal pyrogenic exotoxins
ATE443768T1 (de) * 1998-07-10 2009-10-15 U S Medical Res Inst Of Infect Impfstoff gegen staphylokokken-vergiftung
GB0118155D0 (en) 2001-07-25 2001-09-19 Lorantis Ltd Superantigen
BRPI0408167B1 (pt) * 2003-03-07 2014-10-21 Wyeth Corp Conjugados de polissacarídeo-proteína veículo adesina da superfície estafilocócica para imunização contra infecções nosocomiais
US20050008633A1 (en) 2003-05-19 2005-01-13 Advanced Inhalation Research Inc. Chemical and physical modulators of bioavailability of inhaled compositions
US7754225B2 (en) 2006-07-20 2010-07-13 Glaxosmithkline Biologicals S.A. Method of protecting against staphylococcal infection
WO2008154101A1 (en) * 2007-06-06 2008-12-18 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Psm peptides as vaccine targets against methicillin-resistant staphylococcus aureus
AU2008292897B2 (en) * 2007-08-31 2015-01-22 University Of Chicago Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
WO2012109167A1 (en) 2011-02-08 2012-08-16 Integrated Biotherapeutics, Inc. Immunogenic composition comprising alpha-hemolysin oligopeptides
WO2012170097A2 (en) * 2011-03-16 2012-12-13 Regents Of The University Of Minnesota Compositions and methods for inducing immune responses against bacteria in the genus staphylococcus
EP2785368B1 (en) 2011-12-02 2019-03-13 Integrated Biotherapeutics, Inc. Immunogenic composition comprising panton-valentine leukocidin (pvl) derived polypeptides
WO2014205111A1 (en) 2013-06-19 2014-12-24 Integrated Biotherapeutics, Inc. Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof

Also Published As

Publication number Publication date
CA2916231A1 (en) 2014-12-24
US20160185829A1 (en) 2016-06-30
US20180148482A1 (en) 2018-05-31
US10174085B2 (en) 2019-01-08
WO2014205111A1 (en) 2014-12-24
DK3010535T3 (da) 2020-11-30
EP3010535A4 (en) 2017-03-01
EP3010535B1 (en) 2019-08-14
CA2916231C (en) 2024-02-06
EP3010535A1 (en) 2016-04-27
US9815872B2 (en) 2017-11-14
JP2016522259A (ja) 2016-07-28
JP6632974B2 (ja) 2020-01-22

Similar Documents

Publication Publication Date Title
PT3010535T (pt) Péptidos de toxoide derivados de modulina solúvel em fenol, delta toxina, superantigénios e suas fusões
IL240055A0 (en) Methods, systems and software for identifying biomolecules with interaction components
EP2812245A4 (en) AUTOPILOT SYSTEM AND COMPONENTS AND METHOD THEREFOR
GB201608256D0 (en) Solvent-free processing, system and methods
EP2968775A4 (en) Drug cassette, autoinjector, and autoinjector system
EP2968760A4 (en) Drug cassette, autoinjector, and autoinjector system
EP2850059A4 (en) CONJUGATES OF MEDICATION, METHODS OF CONJUGATION AND USE THEREOF
GB201313527D0 (en) A valve which depressurises, and a valve system
ZA201503467B (en) M. tuberculosis vaccines
SG11201604660VA (en) Drug delivery system.
EP2972257A4 (en) Improved techniques, systems and machine readable programs for magnetic resonance
ZA201602603B (en) Methods for oxime conjugation toketone-modified polypeptides
EP3110484A4 (en) Powder inhaler, system and methods
GB201614162D0 (en) Antibodies, uses thereof and conjugates thereof
EP3394718A4 (en) SYSTEMS AND METHOD FOR REGISTERING CARD AUTHENTICATION READINGS
IL237852A0 (en) Antibodies against amphigoline, medical preparations containing them and their use
EP2955977B8 (en) Induction heating coil, and induction heating system using same
SG11201507608PA (en) Toxoid, compositions and related methods
IL257434A (en) Mrka polypeptides, antibodies, and uses thereof
IL258056A (en) Foxm1-derived peptide and a component containing it
IL247838A0 (en) Australolysin, a functionally related variant thereof, an extract containing Australolysin and uses thereof
SG11201507578PA (en) Toxoid, compositions and related methods
PL2945890T3 (pl) System z kręgiem i urządzeniem przenośnikowym dla kręgu
SG11201706420SA (en) Peptides having affinity for polydimethylsiloxane, and uses thereof
ZA201907715B (en) Vaccine comprising clostridium toxoids